ASX - By Stock
|
HCT |
Re:
Ann: Update on Sales and Distribution Agreements for Natshield
|
|
brear
|
480 |
90K |
5 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
480
|
90K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Reverses HIV-Induced Immune Evasion
|
|
brear
|
99 |
47K |
0 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
99
|
47K
|
0
|
|
ASX - By Stock
|
SDL |
Re:
Ann: Postponement of EGM
|
|
brear
|
32 |
14K |
6 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
32
|
14K
|
6
|
|
ASX - By Stock
|
ARV |
Re:
Don't lose sight of the game folks
|
|
brear
|
95 |
41K |
1 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
95
|
41K
|
1
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Voluntary Suspension
|
|
brear
|
424 |
143K |
10 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
424
|
143K
|
10
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Voluntary Suspension
|
|
brear
|
424 |
143K |
10 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
424
|
143K
|
10
|
|
ASX - By Stock
|
HCT |
Re:
Holista CollTech joins forces with GICC to develop works first nasal sanitiser
|
|
brear
|
2.0K |
635K |
1 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
2.0K
|
635K
|
1
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Appendix 4C Quarterly Cashflow Report and Commentary
|
|
brear
|
403 |
115K |
5 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
403
|
115K
|
5
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Appendix 4C Quarterly Cashflow Report and Commentary
|
|
brear
|
403 |
115K |
2 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
403
|
115K
|
2
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Appendix 4C Quarterly Cashflow Report and Commentary
|
|
brear
|
403 |
115K |
2 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
403
|
115K
|
2
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Appendix 4C Quarterly Cashflow Report and Commentary
|
|
brear
|
403 |
115K |
2 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
403
|
115K
|
2
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Maiden Sales of $1.4M for 80Less Sugar Formulation
|
|
brear
|
68 |
23K |
2 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
68
|
23K
|
2
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Maiden Sales of $1.4M for 80Less Sugar Formulation
|
|
brear
|
68 |
23K |
0 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
68
|
23K
|
0
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Maiden Sales of $1.4M for 80Less Sugar Formulation
|
|
brear
|
68 |
23K |
2 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
68
|
23K
|
2
|
|
Breaking News
|
|
Re:
CORONA VIRUS. Is it out of control?
|
|
brear
|
7.6K |
12M |
3 |
28/02/20 |
28/02/20 |
Breaking News
|
7.6K
|
12M
|
3
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Retraction of Statements and Clarification
|
|
brear
|
177 |
178K |
6 |
25/02/20 |
25/02/20 |
ASX - By Stock
|
177
|
178K
|
6
|
|
ASX - By Stock
|
HCT |
Competitor landscape?
|
|
brear
|
2 |
2.2K |
0 |
21/02/20 |
21/02/20 |
ASX - By Stock
|
2
|
2.2K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
chart weekly
|
|
brear
|
1.7K |
10M |
0 |
11/02/20 |
11/02/20 |
ASX - By Stock
|
1.7K
|
10M
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell receives new patents for CelGro
|
|
brear
|
53 |
25K |
0 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
53
|
25K
|
0
|
|
ASX - By Stock
|
SDL |
Re:
Ann: Appendix 2A
|
|
brear
|
11 |
7.5K |
3 |
04/02/20 |
04/02/20 |
ASX - By Stock
|
11
|
7.5K
|
3
|
|
ASX - By Stock
|
SDL |
Re:
Ann: Appendix 2A
|
|
brear
|
11 |
7.5K |
0 |
04/02/20 |
04/02/20 |
ASX - By Stock
|
11
|
7.5K
|
0
|
|
ASX - By Stock
|
SDL |
Re:
Ann: Appendix 2A
|
|
brear
|
11 |
7.5K |
1 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
11
|
7.5K
|
1
|
|
ASX - By Stock
|
SDL |
Re:
Ann: Quarterly Activities Report
|
|
brear
|
77 |
48K |
3 |
28/01/20 |
28/01/20 |
ASX - By Stock
|
77
|
48K
|
3
|
|
ASX - By Stock
|
ASV |
Re:
Ann: PS&C Ltd Form 603 - Notice of Initial Substantial Holder
|
|
brear
|
9 |
4.0K |
0 |
23/01/20 |
23/01/20 |
ASX - By Stock
|
9
|
4.0K
|
0
|
|
ASX - By Stock
|
SDL |
Re:
Ann: Chairman's Address to Shareholders
|
|
brear
|
81 |
40K |
9 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
81
|
40K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
brear
|
2.0K |
1.0M |
2 |
10/12/19 |
10/12/19 |
ASX - By Stock
|
2.0K
|
1.0M
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Free rotator cuff repair in Perth
|
|
brear
|
27 |
12K |
1 |
06/12/19 |
06/12/19 |
ASX - By Stock
|
27
|
12K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
brear
|
145 |
76K |
2 |
02/12/19 |
02/12/19 |
ASX - By Stock
|
145
|
76K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
brear
|
145 |
76K |
7 |
02/12/19 |
02/12/19 |
ASX - By Stock
|
145
|
76K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
brear
|
2.0K |
1.0M |
4 |
01/11/19 |
01/11/19 |
ASX - By Stock
|
2.0K
|
1.0M
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Up up and away
|
|
brear
|
1 |
1.3K |
0 |
07/10/19 |
07/10/19 |
ASX - By Stock
|
1
|
1.3K
|
0
|
|
ASX - By Stock
|
NUH |
Re:
Ann: Annual Report
|
|
brear
|
52 |
26K |
3 |
14/09/19 |
14/09/19 |
ASX - By Stock
|
52
|
26K
|
3
|
|
ASX - By Stock
|
NUH |
Re:
Ann: Annual Report
|
|
brear
|
52 |
26K |
8 |
14/09/19 |
14/09/19 |
ASX - By Stock
|
52
|
26K
|
8
|
|
ASX - By Stock
|
PCL |
Re:
Ann: Presentation to the Africa Oil & Gas Conference
|
|
brear
|
5 |
4.4K |
0 |
02/09/19 |
02/09/19 |
ASX - By Stock
|
5
|
4.4K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: CelGro Study Validates High Quality Nerve Repair
|
|
brear
|
68 |
36K |
2 |
26/07/19 |
26/07/19 |
ASX - By Stock
|
68
|
36K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: CelGro Study Validates High Quality Nerve Repair
|
|
brear
|
68 |
36K |
2 |
25/07/19 |
25/07/19 |
ASX - By Stock
|
68
|
36K
|
2
|
|
ASX - By Stock
|
SDL |
Re:
Ann: ANS: Market Update
|
|
brear
|
137 |
75K |
5 |
02/07/19 |
02/07/19 |
ASX - By Stock
|
137
|
75K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
brear
|
2.0K |
1.0M |
2 |
25/06/19 |
25/06/19 |
ASX - By Stock
|
2.0K
|
1.0M
|
2
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
brear
|
2.0K |
1.0M |
1 |
17/06/19 |
17/06/19 |
ASX - By Stock
|
2.0K
|
1.0M
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Investor Update
|
|
brear
|
58 |
29K |
1 |
30/05/19 |
30/05/19 |
ASX - By Stock
|
58
|
29K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
brear
|
53 |
26K |
3 |
28/05/19 |
28/05/19 |
ASX - By Stock
|
53
|
26K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Investor Update
|
|
brear
|
58 |
29K |
2 |
21/05/19 |
21/05/19 |
ASX - By Stock
|
58
|
29K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Becoming a substantial holder
|
|
brear
|
65 |
25K |
3 |
16/05/19 |
16/05/19 |
ASX - By Stock
|
65
|
25K
|
3
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Quarterly Activities Report and Cash Flow Report
|
|
brear
|
10 |
3.9K |
0 |
08/05/19 |
08/05/19 |
ASX - By Stock
|
10
|
3.9K
|
0
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Positive Scoping Studies for Airijoki and Koitelainen
|
|
brear
|
27 |
7.1K |
1 |
08/05/19 |
08/05/19 |
ASX - By Stock
|
27
|
7.1K
|
1
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Quarterly Activities Report and Cash Flow Report
|
|
brear
|
10 |
3.9K |
0 |
08/05/19 |
08/05/19 |
ASX - By Stock
|
10
|
3.9K
|
0
|
|
ASX - By Stock
|
BUB |
Re:
750mil MC with no profits
|
|
brear
|
52 |
29K |
8 |
07/05/19 |
07/05/19 |
ASX - By Stock
|
52
|
29K
|
8
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Quarterly Activities Report and Cash Flow Report
|
|
brear
|
10 |
3.9K |
2 |
06/05/19 |
06/05/19 |
ASX - By Stock
|
10
|
3.9K
|
2
|
|
ASX - By Stock
|
BUB |
Re:
Ann: Bubs Launches Australia's First Organic Grass-Fed Formula
|
|
brear
|
43 |
32K |
2 |
06/05/19 |
06/05/19 |
ASX - By Stock
|
43
|
32K
|
2
|
|
ASX - By Stock
|
PUR |
Re:
Ann: Quarterly Activities Report and Cash Flow Report
|
|
brear
|
10 |
3.9K |
0 |
30/04/19 |
30/04/19 |
ASX - By Stock
|
10
|
3.9K
|
0
|
|